Brand Name(s): Trusopt; Cosopt (combined with

timolol maleate)
CAS nš: 130693-82-2
(door ZOLE uh mide)

About Dorzolamide

This new site is dedicated exclusively to dorzolamide.

It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about dorzolamide on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.

This unique site will also offer you inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total dorzolamide experience! 

Why is this medication prescribed?

Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (e.g., ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness.

This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. 

See more Product Info

Latest News

Glaucoma and ADHD reimbursement criticised

The new lists of reimbursed drugs released for public consultation by the Ministry of Health on 5...

[more]

Tips on identifying symptoms of glaucoma and getting treatment

Chances are you may have heard of glaucoma, a chronic disease affecting the eye that can eventually...

[more]

Glaucoma can worsen during pregnancy

New York (Reuters Health) - For women with glaucoma, pregnancy usually has no effect on their eye...

[more]

All you need to know about glaucoma

Glaucoma is an eye defect. Many people have called it a thief of sight because glaucoma can lead to...

[more]

The effectiveness and safety of topical dorzolamide in pediatric patients

Few children between the ages of 1 and 6 suffered side effects in a study assessing the...

[more]

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.